Details for 2015739042
Up to date per 01.04.2026
Actions
Details for 2015739042
Granted/Registered
European Patent
19.04.2017 A
05.08.2020 B1
12.06.2014
US
201462011315 P
C07D 239/42 20060101AFI20151223BHEP
Owner
GlaxoSmithKline LLCCorporation Service Company 251 Little Falls Drive Wilmington, DE 19808US
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
BROWN, Brandon, H.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
CARRA, Ernest, A.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
HEMENWAY, Jeffrey, N.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
MORRISON, Henryc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
REYNOLDS, Troyc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
SHI, Bingc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
STEFANIDIS, Dimitriosc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
WANG, Fangc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
WARR, Matthew, Robertc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
WHITNEY, James, Andrewc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
XIN, Yanc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US
Information about Fees